Search

everythinglearnresearchcommunity

for

Search:↓

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

Dupilumab for skin problems might reactivate hair loss in some patients.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

Dupilumab can help regrow hair in alopecia areata but stopping it may cause hair loss again.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

Different genes are linked to various types of hair loss.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

Genetics play a role in acne, but how exactly they contribute is not fully understood.

Dupilumab may help treat alopecia areata, but more research is needed.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

IL-1 alpha stops hair follicle growth and hair production.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Testosterone increases cell growth and reduces IL-6 in gum cells.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

These gene variations are not linked to alopecia areata in Egyptians.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

Red light at 627 nm can safely trigger IL-4 release in skin cells, potentially helping treat inflammatory skin conditions.

IL-1 receptor absence in mice leads to skin cysts and changes in immune response after UVB exposure.

Mice with extra human KLK14 had hair and skin problems, including weaker cell bonds and inflammation, linked to Netherton syndrome.

TLR4 is important in aging-related diseases and could be a new treatment target.